ProxyCRO

06/06/2014

http://online.wsj.com/articles/astrazeneca-issues-update-on-cancer-drug-pipeline-1401780716

AstraZeneca issued an upbeat update on its cancer treatment pipeline, a key part of its efforts to boost sales, in its first drug disclosure since rejecting a $120 billion takeover bid from Pfizer.

06/06/2014

http://www.forbes.com/sites/matthewherper/2014/06/03/after-battle-with-pfizer-astrazeneca-ceo-promises-growth/

A day before our scheduled interview, AstraZeneca CEO Pascal Soriot barged into another meeting thinking he was supposed to be there. The next day he said hello as if we were old friends. Fresh from battling off a $117 billion acquisition “discussion” — his word — from Pfizer, he seemed [...]

06/06/2014

"Since the last assessment of the public's perception of, and experiences in, clinical trials eight years ago, we've seen marked improvements in public perceptions about clinical research and participation"

http://www.dddmag.com/news/2014/06/public-perception-clinical-trials-markedly-improved

inVentiv Clinical Trial Recruitment Solutions, in collaboration with The Center for Information and Study on Clinical Research Participation, has released the results of research showing public perceptions of clinical trials has improved – good news for companies hoping to recruit for a trial. Read…

06/06/2014

The company expects to finish filing for approval of nivolumab as a third-line treatment for non-small cell lung cancer before the end of 2014.

http://www.businessweek.com/ap/2014-05-15/bristol-myers-slumps-on-cancer-drug-study-data

NEW YORK (AP) — Shares of Bristol-Myers Squibb slumped Thursday after the drugmaker reported disappointing clinical trial data for an experimental cancer treatment.

05/02/2014

Ceritinib for patient with ALK gene http://www.medscape.com/viewarticle/824305

This is the second targeted agent specifically for ALK-positive non-small cell lung cancer patients, indicated for patients who have already used crizotinib.

05/02/2014

Fda approves Novartis drug for lung cancer treatment http://in.mobile.reuters.com/article/idINL2N0NL1Z820140429?irpc=932

01/27/2014

http://jobview.monster.com/Clinical-Research-Associate-Job-Saint-Petersburg-FL-US-129388235.aspx?WT.mc_n=Indeed_US&from=indeed

Clinical Research Associate job in Saint Petersburg, Florida, US. Read the Clinical Research Associate job description and find other Bay Area Heart Center jobs at Monster.

01/27/2014

https://carecentrix-openhire.silkroad.com/epostings/index.cfm?fuseaction=app.dspjob&jobid=2244&company_id=16295&version=1&jobBoardId=1112

The core function is to review utilization information concerning patient care for CareCentrix and to match those needs to available care options, within the CareCentrix guidelines and specific plan payer criteria. Handles verification of all refe...

01/09/2014

http://seekingalpha.com/article/1925021-bristol-myers-squibb-vs-roche-in-the-brain-cancer-race

In January, Bristol-Myers Squibb (BMY), will start a Phase 2 study in patients with glioblastoma. The trial is part of a series in which Bristol combines its experimental drug, nivolumab, with the approved Yervoy, and test it

10/17/2013

Drugs fail their clinical trials for all kinds of reasons. Sometimes, it's related to efficacy; sometimes, it's safety related. Most of the time,

10/05/2013

There will be those who’ll argue that this is a transparency issue for the biopharmaceutical industry and that, by “hiding” these data, the industry is harming the public. I disagree.

10/04/2013

The U.S. Food and Drug Administration intends to regulate only mobile apps that are medical devices and could pose a risk to a patient's safety if they do not function as intended.